1. Home
  2. GNPX vs MEGL Comparison

GNPX vs MEGL Comparison

Compare GNPX & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.01

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Logo Magic Empire Global Limited

MEGL

Magic Empire Global Limited

N/A

Current Price

$1.09

Market Cap

5.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GNPX
MEGL
Founded
2009
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
5.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
GNPX
MEGL
Price
$2.01
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
834.0K
12.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
76.33
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.87
52 Week High
$12.97
$2.62

Technical Indicators

Market Signals
Indicator
GNPX
MEGL
Relative Strength Index (RSI) 47.73 51.21
Support Level $1.88 $0.88
Resistance Level $2.51 $1.18
Average True Range (ATR) 0.13 0.05
MACD 0.02 0.02
Stochastic Oscillator 58.93 57.60

Price Performance

Historical Comparison
GNPX
MEGL

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: